0000902664-24-003030.txt : 20240423 0000902664-24-003030.hdr.sgml : 20240423 20240423161531 ACCESSION NUMBER: 0000902664-24-003030 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240419 FILED AS OF DATE: 20240423 DATE AS OF CHANGE: 20240423 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nichols Weston CENTRAL INDEX KEY: 0001746376 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 24864991 MAIL ADDRESS: STREET 1: 151 CALLE DE SAN FRANCISCO STREET 2: SUITE 200, PMB 1237 CITY: SAN JUAN STATE: PR ZIP: 00901-1607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynx1 Capital Management LP CENTRAL INDEX KEY: 0001910456 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 24864992 BUSINESS ADDRESS: STREET 1: 151 CALLE DE SAN FRANCISCO STREET 2: SUITE 200 PMB 1237 CITY: SAN JUAN STATE: PR ZIP: 00901-1607 BUSINESS PHONE: 703-963-7214 MAIL ADDRESS: STREET 1: 151 CALLE DE SAN FRANCISCO STREET 2: SUITE 200 PMB 1237 CITY: SAN JUAN STATE: PR ZIP: 00901-1607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0508 4 2024-04-19 0 0001783328 TScan Therapeutics, Inc. TCRX 0001910456 Lynx1 Capital Management LP 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 PUERTO RICO 0 0 1 0 0001746376 Nichols Weston 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 PUERTO RICO 0 0 1 0 0 Pre-funded Warrant (right to buy) 0.0001 2024-04-19 4 P 0 5000000 7.1299 A Common Stock 5000000 5000000 I See footnote Subject to the terms and conditions set forth in the Pre-funded Warrant, the holder thereof may, at any time and from time to time on or after April 19, 2024, exercise the Pre-funded Warrant until it has been exercised in full. The Pre-funded Warrants reported herein contain an exercise limitation prohibiting the holder from exercising the Pre-Funded Warrants until such time as the holder, together with the Reporting Persons and certain other related parties, would not beneficially own after any such exercise more than 4.99% of the then issued and outstanding Common Stock (the "Blocker"). Due to the Blocker, the Pre-funded Warrants beneficially owned by the Reporting Persons are not presently exercisable. The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member 2024-04-23 /s/ Weston Nichols 2024-04-23